Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy.
Guex
A C
AC
Medizinische Universitäts-Poliklinik, Kantonsspital Basel, CH-4031 Basel, Switzerland.
Radziwill
A J
AJ
Bucher
H C
HC
D017088:AIDS-Related Opportunistic Infections / Q000276:immunology / Q000517:prevention & control*; D000328:Adult; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003049:Coccidiostats / Q000627:therapeutic use; D004660:Encephalitis / Q000276:immunology / Q000517:prevention & control; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D016781:Toxoplasmosis, Cerebral / Q000276:immunology / Q000517:prevention & control*
D019380:Anti-HIV Agents; D003049:Coccidiostats